As imatinib is known to reduce brain edema and hemorrhage after stroke by inhibiting the PDGF-CC pathway and thus improving BBB integrity [9], [10], we hypothesized that imatinib may also affect the BBB during neuroinflammation. Here, CXCR1 is linked to stroke disorder.